KRM Ayurveda IPO is a Book Building listing on NSE SME exchange, with an ipo size of ₹ [●] Cr. The company is based in New Delhi and caters to Healthcare - Hospitals And Clinic sector. Nexgen Financial Solutions is the merchant banker of KRM Ayurveda IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 22nd September 2025.
KRM Ayurveda IPO posted revenues of ₹ 76.55 Cr. and PAT of ₹ 12.09 Cr. in FY25 on annualised basis.Financial results of KRM Ayurveda IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | FY25 | FY24 | FY23 | ||
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 66.78 | 43.91 | 39.47 | ||
Net Worth | 23.87 | 11.77 | 8.36 | ||
Total Debt | 31.19 | 23.17 | 19.87 | ||
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
76.55 | 67.15 | 89.28 | ||
EBITDA
EBITDA on annualised basis |
19.49 | 7.73 | 11.10 | ||
PAT
PAT on annualised basis |
12.09 | 3.41 | 7.59 |
KRM Ayurveda IPO PAT Margin is 15.79 % , ROCE (Return on Capital Employed) is 43.33 % as per latest financial. The below table shows KRM Ayurveda IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | FY25 | FY24 | FY23 |
---|---|---|---|
EBITDA Margin (%) | 25.46 | 11.51 | 12.43 |
PAT Margin (%) | 15.79 | 5.08 | 8.50 |
EPS (₹) | 8.06 | 2.27 | 5.07 |
ROE (%) | 50.65 | 28.97 | 90.79 |
ROCE (%) | 43.33 | 20.80 | 40.34 |
ROA (%) | 18.10 | 7.77 | 19.23 |
Debt to Equity | 1.31 | 1.97 | 2.38 |
The market Capitalisation of KRM Ayurveda IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The KRM Ayurveda IPO prospectus highlights an Return on Equity (ROE) of 50.65 % , Return on Assets (ROA) of 18.10 %, and an EBITDA Margin of 25.46 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows KRM Ayurveda IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of KRM Ayurveda IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The KRM Ayurveda IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
KRM Ayurveda IPO reported revenue of ₹ 76.55 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from KRM Ayurveda IPO provide insights into sales growth, market demand, and business scalability.
KRM Ayurveda recorded an EBITDA of ₹ 19.49 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
KRM Ayurveda Profit After Tax (PAT) is ₹ 12.09 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
KRM Ayurveda operates in Healthcare - Hospitals And Clinic and Network Of Hospitals And Clinics Across Multiple Cities In India. The Issue is listed on NSE SME in Oct, 2025. KRM Ayurveda IPO size was with Issue price of .
Merchant Banker(s) of KRM Ayurveda IPO: Nexgen Financial Solutions Private Limited
KRM Ayurveda IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
KRM Ayurveda IPO listed at a listing price of against the offer price of .
The current market price of KRM Ayurveda is .
Why Us?